Engraftment after myeloablative doses of 131I-metaiodobenzylguanidine followed by autologous bone marrow transplantation for treatment of refractory neuroblastoma. (Q45948464)

From Wikidata

Jump to navigation Jump to search

scientific article published in June 1998

Language	Label	Description	Also known as
English	Engraftment after myeloablative doses of 131I-metaiodobenzylguanidine followed by autologous bone marrow transplantation for treatment of refractory neuroblastoma.	scientific article published in June 1998

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9589082%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Engraftment after myeloablative doses of 131I-metaiodobenzylguanidine followed by autologous bone marrow transplantation for treatment of refractory neuroblastoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9589082%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9589082%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Robert C Seeger

7

object named as

R C Seeger

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9589082%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Katherine K Matthay

9

object named as

K K Matthay

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9589082%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

author name string

S S Goldberg

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9589082%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

K DeSantes

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9589082%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

J P Huberty

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9589082%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

D Price

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9589082%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

B H Hasegawa

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9589082%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

R Hattner

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9589082%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

publication date

1 June 1998

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9589082%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Pediatric Blood & Cancer

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9589082%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

30

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9589082%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9589082%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

339-346

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9589082%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Treatment of neuroblastoma with metaiodobenzylguanidine: results and side effects

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199806%2930%3A6%3C339%3A%3AAID-MPO7%3E3.0.CO%3B2-F

21 January 2018

Therapeutic use of 131I-metaiodobenzylguanidine (MIBG) in neuroblastoma: a phase II study in nine patients

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199806%2930%3A6%3C339%3A%3AAID-MPO7%3E3.0.CO%3B2-F

21 January 2018

Phase I/II study of iodine 131 metaiodobenzylguanidine in chemoresistant neuroblastoma: a United Kingdom Children's Cancer Study Group investigation

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199806%2930%3A6%3C339%3A%3AAID-MPO7%3E3.0.CO%3B2-F

21 January 2018

Critical observations on neuroblastoma treatment with 131-I-metaiodobenzylguanidine at diagnosis

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199806%2930%3A6%3C339%3A%3AAID-MPO7%3E3.0.CO%3B2-F

21 January 2018

First line targeted radiotherapy, a new concept in the treatment of advanced stage neuroblastoma

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199806%2930%3A6%3C339%3A%3AAID-MPO7%3E3.0.CO%3B2-F

21 January 2018

Phase I dose escalation of 131I-metaiodobenzylguanidine with autologous bone marrow support in refractory neuroblastoma

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199806%2930%3A6%3C339%3A%3AAID-MPO7%3E3.0.CO%3B2-F

21 January 2018

Patterns of relapse after autologous purged bone marrow transplantation for neuroblastoma: a Childrens Cancer Group pilot study.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199806%2930%3A6%3C339%3A%3AAID-MPO7%3E3.0.CO%3B2-F

21 January 2018

High-dose chemoradiotherapy supported by marrow infusions for advanced neuroblastoma: a Pediatric Oncology Group study

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199806%2930%3A6%3C339%3A%3AAID-MPO7%3E3.0.CO%3B2-F

21 January 2018

Radiolabeled-Antibody Therapy of B-Cell Lymphoma with Autologous Bone Marrow Support

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199806%2930%3A6%3C339%3A%3AAID-MPO7%3E3.0.CO%3B2-F

21 January 2018

Meta-iodobenzylguanidine uptake in platelets, megakaryoblastic leukaemia cell lines MKPL-1 and CHRF-288-11 and erythroleukaemic cell line HEL

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199806%2930%3A6%3C339%3A%3AAID-MPO7%3E3.0.CO%3B2-F

21 January 2018

International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199806%2930%3A6%3C339%3A%3AAID-MPO7%3E3.0.CO%3B2-F

21 January 2018

Multi-modality megatherapy with [131I]metaiodobenzylguanidine, high dose melphalan and total body irradiation with bone marrow rescue: Feasibility study of a new strategy for advanced neuroblastoma

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199806%2930%3A6%3C339%3A%3AAID-MPO7%3E3.0.CO%3B2-F

21 January 2018

Treatment of neuroblastoma with 131I-MIBG: dosimetric problems and perspectives

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199806%2930%3A6%3C339%3A%3AAID-MPO7%3E3.0.CO%3B2-F

21 January 2018

131-I-metaiodobenzylguanidine treatment in patients with refractory advanced neuroblastoma

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199806%2930%3A6%3C339%3A%3AAID-MPO7%3E3.0.CO%3B2-F

21 January 2018

[131I]-metaiodobenzylguanidine in the treatment of metastatic neuroblastoma. Clinical, pharmacological and dosimetric aspects

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199806%2930%3A6%3C339%3A%3AAID-MPO7%3E3.0.CO%3B2-F

21 January 2018

Improved survival at 2 and 5 years in the LMCE1 unselected group of 72 children with stage IV neuroblastoma older than 1 year of age at diagnosis: is cure possible in a small subgroup?

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199806%2930%3A6%3C339%3A%3AAID-MPO7%3E3.0.CO%3B2-F

21 January 2018

Prognostic value of immunocytologic detection of bone marrow metastases in neuroblastoma

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199806%2930%3A6%3C339%3A%3AAID-MPO7%3E3.0.CO%3B2-F

21 January 2018

Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199806%2930%3A6%3C339%3A%3AAID-MPO7%3E3.0.CO%3B2-F

21 January 2018

Identifiers

10.1002/(SICI)1096-911X(199806)30:6<339::AID-MPO7>3.0.CO;2-F

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9589082%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9589082%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45948464&oldid=2186418221"